Use of phosphodiesterase-5 inhibitors by college students

• Autor(a) principal: Freitas, Vanessa Mello de
• Data de Publicação: 2008
• Outros Autores: Menezes, Fabiana Gatti de, Antonialli, Michele Melo Silva, Nascimento, Jorge Willian Leandro
• Tipo de documento: Artigo
• Idioma: por; eng
• Título da fonte: Revista de Saúde Pública
• Texto Completo: https://www.revistas.usp.br/rsp/article/view/32521
• topic: Estudantes; Automedicação; Disfunção Erétil; Inibidores de Fosfodiesterase^i1^sadministração & dosa; Questionários^i1^sutiliza; Students; Self Medication; Erectile Dysfunction; Phosphodiesterase Inhibitors^i2^sadministration & dos; Questionnaires^i2^sutilizat; Estudiantes; Automedicación; Disfunción Eréctil; Inhibidores de Fosfodiesterasa^i3^sadministración & dosificac; Cuestionario^i3^sutilizac

The objective of this study was to identify the use of phosphodiesterase type 5 inhibitors among university students from the city of Sao Paulo (SP) in Brazil. Male students (n=350) replied to a questionnaire about diagnosis of erectile dysfunction, the frequency and reason for the use of phosphodiesterase type 5 inhibitors, the specific medication used, whether their use was accompanied by a medical prescription and any reported side-effects. The results shows that a total of 53 (14.7%) students had already used this kind of medication without a prescription or medical diagnosis for erectile dysfunction, of which 53% reported using sildenafil, 37% tadalafil and 10% vardenafil. The main adverse side-effects reported were headache (23%) and flushing (10%) and the main reasons for using the inhibitor were curiosity (70%) and erectile improvement (12%).